BROKERS’ NOTES: Buy Novo Nordisk, sell Bristol Myers Squibb
Sell: Bristol Myers Squibb Bristol Myers Squibb (BMY) is a global biopharmaceutical company engaged in the discovery, development and delivery of transformational medicines for serious diseases. As US markets hit record highs, BMY is down 18% year to date. …